Arstat Pharmaceuticals addresses, for the first time, critical unmet needs in women’s health. Below are Arstat Pharmaceuticals’ key success factors. 1. Founder & President/CSO is a top expert (J&J, Pfizer) in Women’s Health and a co-inventor of the leading US birth control pill (sales translated in $1.8B in today’s market). 2. Strong product pipeline, including 2 Phase III-ready assets (confirmed by the FDA) and 2 likely global blockbusters. All products will be developed via a rapid 505(b)(2) pathway. 3. Addressing huge unmet needs in women’s health, an addressable US market is 50 million women. a. First-ever contraceptive product designed for women with high BMI (disproportionally impacted by the overruling of Roe vs. Wade). b. A first-in-category treatment for uterine fibroids and endometriosis c. A first-in-category treatment for heavy and painful menstrual periods d. An optimal oral contraceptive brand for normal-weight women 4. Outstanding IP: Extensive patent portfolio (13 granted US and EU patents, and more in progress) 5. Seasoned Management Team and Stellar Advisory Board Please contact me to learn more about this investment opportunity.

1221 Ocean Avenue
Santa Monica, California
United States
Map It